United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018Global Markets DirectJanuary 7, 2013 155 Pages - SKU: GMD4939664 |
|
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis,
|
read more...
|
$4,500.00
|
|
CompetitiveWatch Hematology and Flow Cytometry: Strategic Assessments of Major Suppliers
5/14/2013 | published by: Venture Planning Group
This report presents strategic analyses of the major current and emerging suppliers in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 30 pages Please note: The
|
read more...
|
$1,850.00
|
|
2013 Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
5/14/2013 | published by: Venture Planning Group
This new 320-page report from Venture Planning Group contains 83 tables and provides analysis of the global tumor markers and special chemistry testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares,
|
read more...
|
$8,500.00
|
|
CompetitiveWatch Tumor Markers: Strategic Assessments of Major Suppliers
5/14/2013 | published by: Venture Planning Group
This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: Sales Product portfolios Distribution tactics Technological know-how New products in R&D Collaborative arrangements Business strategies. Contains 80
|
read more...
|
$2,500.00
|
|
2013 Analysis of the UK Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/22/2013 | published by: Venture Planning Group
Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next
|
read more...
|
$6,100.00
|
|
2013 Analysis of the German Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/19/2013 | published by: Venture Planning Group
This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact
|
read more...
|
$6,100.00
|
|
2013 Analysis of the Japanese Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/19/2013 | published by: Venture Planning Group
This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact
|
read more...
|
$7,600.00
|
|
2013 Analysis of the Japanese Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/22/2013 | published by: Venture Planning Group
Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next
|
read more...
|
$7,500.00
|
|
Analysis of the Global In Vitro Diagnostics Market
5/2/2013 | published by: Frost & Sullivan
Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. This research deliverable leverages primary research, secondary sources, and Frost & Sullivan’s
|
read more...
|
$6,000.00
|
|
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2013 The mammalian target of rapamycin (mTOR) is an intracellular kinase that controls the production of proteins through its regulation of translational machinery. mTOR-activated proteins promote several hallmarks
|
read more...
|
$5,621.25
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Hematology & Oncology Reports